Vanguard Capital Management
ABBV icon

Vanguard Capital Management’s AbbVie ABBV Stock Holding History

Vanguard Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29B Buy
115,396,098
+515,774
+0.4% +$111M 0.62% 23
2026
Q1 		$25B Buy
+114,880,324
New +$25.5B 0.62% 21

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Capital Management's ABBV Position: Q2 2026 in Review

Vanguard Capital Management increased its AbbVie (ABBV) stake by 0.45% in Q2 2026, buying an estimated $111M and bringing the position to 115,396,098 shares worth $29B. The position accounts for 0.62% of the portfolio, ranked #23.

Vanguard Capital Management first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vanguard Capital Management held 115,396,098 shares of AbbVie worth $29B as of Q2 2026.
  • Vanguard Capital Management bought 515,774 AbbVie shares in Q2 2026, an estimated $111M.
  • AbbVie made up 0.62% of Vanguard Capital Management's portfolio in Q2 2026, its #23 holding.
  • Vanguard Capital Management first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
  • 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.